Cargando…
Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
Designing studies of immunotherapy is limited due to a lack of pre-clinical models that reliably predict effective immunotherapy responses. To address this gap, we developed humanized mouse models of colorectal cancer (CRC) incorporating patient-derived xenografts (PDX) with human peripheral blood m...
Autores principales: | Kanikarla Marie, Preeti, Sorokin, Alexey V., Bitner, Lea A., Aden, Rebecca, Lam, Michael, Manyam, Ganiraju, Woods, Melanie N., Anderson, Amanda, Capasso, Anna, Fowlkes, Natalie, Overman, Michael J., Menter, David G., Kopetz, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532947/ https://www.ncbi.nlm.nih.gov/pubmed/36212401 http://dx.doi.org/10.3389/fonc.2022.994333 |
Ejemplares similares
-
Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy
por: Kanikarla-Marie, Preeti, et al.
Publicado: (2018) -
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
por: Sorokin, Alexey V., et al.
Publicado: (2022) -
The Provocative Roles of Platelets in Liver Disease and Cancer
por: Kanikarla Marie, Preeti, et al.
Publicado: (2021) -
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
por: Raghav, Kanwal, et al.
Publicado: (2016) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAF(V600E)-Mutant Colorectal Cancer
por: Napolitano, Stefania, et al.
Publicado: (2023)